Related Experiment Video
Updated: Oct 30, 2025

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice
Published on: July 12, 2018
Gastrointestinal Sequelae 3 and 6 Months After Hospitalization for Coronavirus Disease 2019
Anam Rizvi1, Zankhesh Patel1, Yan Liu1
1Division of Gastroenterology, Long Island Jewish Medical Center, Zucker School of Medicine at Hofstra/Northwell, Northwell Health System, New Hyde Park, New York.
Insights
Gastrointestinal symptoms are common in COVID-19 patients. The SARS-CoV-2 virus may cause these symptoms by targeting angiotensin-converting enzyme-2 receptors in the gut.
Area of Science:
- Gastroenterology
- Virology
- Infectious Diseases
Background:
- Gastrointestinal (GI) symptoms are frequently observed in patients with coronavirus disease 2019 (COVID-19).
- Prevalence rates for GI symptoms in COVID-19 range significantly, from 17.6% to 53% in reported studies.
- The presence of GI symptoms can impact patient management and understanding of the disease spectrum.
Purpose of the Study:
- To explore the prevalence of gastrointestinal symptoms in COVID-19.
- To investigate the underlying mechanisms contributing to GI manifestations in COVID-19 patients.
- To highlight the role of the angiotensin-converting enzyme-2 receptor in SARS-CoV-2 related GI issues.
Main Methods:
- Literature review of studies reporting GI symptoms in COVID-19.
- Analysis of proposed pathogenetic mechanisms for GI involvement.
- Examination of viral tropism and cellular receptor interactions within the GI tract.
Main Results:
- A wide range of gastrointestinal symptom prevalence was confirmed in COVID-19 patients.
- The angiotensin-converting enzyme-2 (ACE2) receptor is identified as a key factor in the GI tract.
- SARS-CoV-2 binding to ACE2 receptors in GI epithelial cells is the proposed mechanism for GI symptoms.
Conclusions:
- Gastrointestinal symptoms are a significant and common feature of COVID-19.
- The ACE2 receptor in the gut plays a crucial role in the pathogenesis of COVID-19 related GI symptoms.
- Further research is warranted to fully elucidate the impact of SARS-CoV-2 on the gastrointestinal system.
Abstract:
Gastrointestinal (GI) symptoms are highly prevalent in coronavirus disease 2019 (COVID-19) ranging from 17.6 % to 53 %.1-4 The proposed mechanism for GI symptoms involves SARS-CoV-2 virus binding to the host cell's angiotensin-converting enzyme-2 receptor, commonly found in GI tract epithelial cells.5.
Related Concept Videos
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Endoscopic Procedures II: Colonoscopy

